Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

California Reports on Inflation’s Impact on State Fee Schedule

The CWCI notes that cumulative percent increases to the Official Medical Fee Schedule have been lower than economy-wide inflation.
Read More →
December 3, 2024

New York Adopts PBM Regulations, with Exemption for Workers' Comp

Healthesystems' Advocacy & Compliance team successfully engaged the DFS to create an exemption for workers' comp PBMs
Read More →
November 21, 2024

New Guide for Preventing Opioid Use Disorder in the Mining Industry

NIOSH and the Mine Safety and Health Administration (MSHA) address the mining industry's unique challenges.
Read More →
November 18, 2024

NCCI Updates Court Case Insights Dashboard

The interactive dashboard tracks significant court cases that could impact workers’ comp.
Read More →
November 18, 2024

NCCI Publishes Annual Carrier Executive Survey

More than 100 carriers were surveyed, and four top industry concerns were noted by NCCI.
Read More →
November 18, 2024

Bureau of Labor Statistics Publishes Workplace Injuries and Illness Report

Private industry employers reported 2.6 million nonfatal workplace injuries and illnesses in 2023, down by 8.4% from 2022.
Read More →
November 18, 2024

Texas Department of Insurance to Host Compliance Webinar

The December 11th webinar will provide an overview of DWC’s regulatory efforts, including administrative and criminal law.
Read More →
November 18, 2024

Texas Considers Mandatory Workers’ Comp Insurance for Construction Contractors

Two bills were pre-filed, with one applying to the general industry and the other applying to contracts for municipal projects.
Read More →
November 18, 2024

AmTrust Publishes 2024 Restaurant Risk Report

The report reviews nearly 130,000 workers’ comp claims from 2018-2023 to identify injury trends the restaurant industry.
Read More →
November 11, 2024
1 30 31 32 33 34 39

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

FDA Issues Naloxone Recommendations for Opioids and OUD Drugs

The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.
Read More

California Releases Online COVID-19 Interactive App

Information from nearly 15,000 COVID-19 claims broken down by industry, demographics, and more.
Read More

Connecticut Enacts Major COVID-19 Presumption

Beyond first responders and healthcare workers, essential workers including grocery store workers are now covered by workers’ comp.
Read More

Department of Labor Audit: COVID-19’s Impact on Comp

A new report on how federal workers’ comp claims have been impacted.
Read More

Virginia Adopts Workplace Safety Standards for COVID-19

Standards are in place for PPE, social distancing, testing procedures, and more.
Read More

FDA Approves Hulio for Rheumatoid Arthritis and More

Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.
Read More
1 30 31 32 33 34 47
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle